Abstract:The Methotrexatum/Layered Double Hydroxide (MTX/LDH) nanohybrids with different properties were prepared by controlling the hydrothermal duration, using the coprecipitation method in alcohol-water solvent and NH3 center dot H2O as precipitator. The structure and morphologies of MTX/LDH were systematically characterized by X-ray diffraction (XRD), transmission electron micrograph (TEM) and fourier transform infrared spectroscopy (FT-IR). Results showed that MTX molecules were intercalated into LDH interlayers as a declining or perpendicular monolayer with the variation of hydrothermal treatment. Indeed,the crystallinity degree (indicated by the sharpness of the diffraction peaks) and particle size were also affected by the hydrothermal duration. The results indicated that MTX/LDH nanohybrids can be synthesized with the highest quality (morphology, monodispersity and crystallinity) at 100 degrees C for 12 h. The high drug-loading capacity of all the nanohybrids indicated that pristine LDH is a good carrier and it seems that capacity has no relation with the particle size. In addition, in vitro release tests of the drugs intercalated into LDH were explored in phosphate buffered saline (PBS) with pH=7.4, and four dissolution-diffusion kinetic models were used to fit the release process. The results indicated that the nanohybrids present two-step release process, i.e., initially fast and then the controlled-release, probably suitable for clinic application. Furthermore, the modified parabolic diffusion model can simulate the release progress better, indicating that MTX/LDH in vitro release process belongs to multi-phase diffusion process via ion exchange. At last, the anticancer efficacy of MTX/LDH hybrids was estimated by the bioassay such as MTT with the human lung cancer (A549). According to the cell-line tests, the drug efficacy is associated with dispersion coefficient 8 closely: the smaller e is, the better the tumor suppression efficiency becomes. The parameter a is determined by both the monodispersity and the particle size.

Synthesis and in Vitro Evaluation of Ph-Sensitive Magnetic Nanocomposites As Methotrexate Delivery System for Targeted Cancer Therapy.

Synthesis and Characterization of Magnetic Polymeric Nanocomposites for Ph-Sensitive Controlled Release of Methotrexate

Synthesis and characterization of magnetic mesoporous core–shell nanocomposites for targeted drug delivery applications

Synthesis and Characterization of Ph-Sensitive Magnetic Nanoparticles As Drug Carriers for Sustained and Controlled Release of Mtx

Preparation of methotrexate bio-magnetically targeted nanoparticles

Magnetic and pH-responsive magnetite/chitosan (core/shell) nanoparticles for dual-targeted methotrexate delivery in cancer therapy

Methotrexate-conjugated and hyperbranched polyglycerol-grafted Fe₃O₄ magnetic nanoparticles for targeted anticancer effects.

Functionalized Magnetic Fe3O4 Nanoparticles for Targeted Methotrexate Delivery in Ovarian Cancer Therapy

The Loading of Luminescent Magnetic Nanocomposites Fe₃O₄@Polyaniline/Carbon Dots for Methotrexate and Its Release Behavior In Vitro .

Facile synthesis of magnetic-/pH-responsive hydrogel beads based on Fe3O4 nanoparticles and chitosan hydrogel as MTX carriers for controlled drug release.

Synthesis and Characterization of Doxorubicin Loaded Ph-Sensitive Magnetic Core-Shell Nanocomposites for Targeted Drug Delivery Applications

Core-shell structure of Fe3O4@MTX-LDH/Au NPs for cancer therapy.

Construction of Methotrexate-Loaded Bi2S3 Coated with Fe/Mn-Bimetallic Doped ZIF-8 Nanocomposites for Cancer Treatment Through the Synergistic Effects of Photothermal/Chemodynamic/Chemotherapy

Methotrexate-Mn2+ Based Nanoscale Coordination Polymers As a Theranostic Nanoplatform for MRI Guided Chemotherapy.

Conjugation of methotrexate onto dedoped Fe 3 O 4 /PPy nanospheres to produce magnetic targeting drug with controlled drug release and targeting specificity for HeLa cells

Folic Acid-Coupled Bovine Serum Albumin-Modified Magnetic Nanocomposites from Quantum-Sized Fe3O4 and Layered Double Hydroxide for Actively Targeted Delivery of 5-Fluorouracil.

Methotrexate-conjugated magnetic nanoparticles for thermochemotherapy and magnetic resonance imaging of tumor

Controllable Synthesis of Methotrexatum/Layered Double Hydroxide Nanohybrids to Improve Their Anticancer Efficacy

Stimuli-responsive nanocomposites for magnetic targeting synergistic multimodal therapy and T1/T2-weighted dual-mode imaging

Methotrexate-loaded Fe-metal organic frameworks: Synthesis, characterizations, and drug release investigations

A theranostic nanocomposite system based on radial mesoporous silica hybridized with Fe3O4 nanoparticles for targeted magnetic field responsive chemotherapy of breast cancer